SC 13D/A

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________
SCHEDULE 13D/A

[Rule 13d-101]

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(a) AND 

AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2(a)

(Amendment No. 13)^*

______________________________
Reinsurance Group of America, Incorporated

(Name of Issuer)

Common Stock, Par Value $0.01 Per Share

(Title of Class of Securities)

759351109

(CUSIP Number)

______________________________
Gwenn L. Carr

MetLife, Inc.

1 MetLife Plaza

27-01 Queens Plaza North

Long Island City, New York 11101

(212) 578-2211

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

______________________________
February 22, 2008

(Date of Event which Requires Filing of this Statement)

        If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this 

  Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.    ¨

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. 
See Rule 13d-7 for other parties to whom copies are to be sent.   

_________________ 
        * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter disclosures provided in a prior cover page. 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act 
of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 

CUSIP No. 759351109			SCHEDULE 13D	(Page 2 of 8)
1	NAMES OF REPORTING PERSONS
	MetLife, Inc.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)   ¨
				(b)   ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS
	Not Applicable
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
	TO ITEM 2(d) or 2(e)			¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
NUMBER OF    SHARES  BENEFICIALLY  OWNED BY  EACH  REPORTING  PERSON WITH		7	SOLE VOTING POWER
			None
		8	SHARED VOTING POWER
			32,243,539
		9	SOLE DISPOSITIVE POWER
			None
		10	SHARED DISPOSITIVE POWER
			32,243,539
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	32,243,539
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
	CERTAIN SHARES    (See Instructions)			¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	52%*
14	TYPE OF REPORTING PERSON  (See Instructions)
	HC
*	This percentage is based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2007.

2

CUSIP No. 759351109			SCHEDULE 13D	(Page 3 of 8)
1	NAMES OF REPORTING PERSONS
	Metropolitan Life Insurance Company
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)   ¨
				(b)   ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS
	Not Applicable
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
	TO ITEM 2(d) or 2(e)			¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	New York
NUMBER OF		7	SOLE VOTING POWER
SHARES			None
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
		8	SHARED VOTING POWER
			32,243,539
		9	SOLE DISPOSITIVE POWER
			None
		10	SHARED DISPOSITIVE POWER
			32,243,539
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	32,243,539
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
	CERTAIN SHARES (See Instructions)			¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	52%*
14	TYPE OF REPORTING PERSON  (See Instructions)
	IC
*	This percentage is based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2007.

3

CUSIP No. 759351109			SCHEDULE 13D	(Page 4 of 8)
1	NAMES OF REPORTING PERSONS
	GenAmerica Financial, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a) ¨
				(b) ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS
	Not Applicable
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
	TO ITEM 2(d) or 2(e)			¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Missouri
NUMBER OF  SHARES  BENEFICIALLY  OWNED BY  EACH  REPORTING  PERSON WITH		7	SOLE VOTING POWER
			None
		8	SHARED VOTING POWER
			32,243,539
		9	SOLE DISPOSITIVE POWER
			None
		10	SHARED DISPOSITIVE POWER
			32,243,539
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	32,243,539
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
	CERTAIN SHARES   (See Instructions)			¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	52%*
14	TYPE OF REPORTING PERSON (See Instructions)
	HC, CO
*	This percentage is based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2007.

4

CUSIP No. 759351109			SCHEDULE 13D	(Page 5 of 8)
1	NAMES OF REPORTING PERSONS
	General American Life Insurance Company
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP			(a)   ¨
				(b)   ¨
3	SEC USE ONLY
4	SOURCE OF FUNDS
	Not Applicable
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
	TO ITEM 2(d) or 2(e)			¨
6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Missouri
NUMBER OF		7	SOLE VOTING POWER
SHARES			None
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
		8	SHARED VOTING POWER
			32,243,539
		9	SOLE DISPOSITIVE POWER
			None
		10	SHARED DISPOSITIVE POWER
			32,243,539
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	32,243,539
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
	CERTAIN SHARES  (See Instructions)			¨
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	52%*
14	TYPE OF REPORTING PERSON (See Instructions)
	IC
*	This percentage is based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2007.

5

     This Statement amends the Schedule 13D Statement, as amended, of (i) MetLife, Inc. (“MLINC”), (ii) Metropolitan Life Insurance Company, a wholly owned subsidiary of MLINC (“MetLife”), (iii) GenAmerica Financial, LLC, a wholly owned subsidiary of MetLife (“GenAm Financial”) and (iv) General American Life Insurance Company, a wholly owned subsidiary of GenAm Financial (“GenAm Life” and collectively with MLINC, MetLife and GenAm Financial, the “Filing Parties”), in respect of shares of common stock, par value $0.01 per share (“Shares”), of Reinsurance Group of America, Incorporated, a Missouri corporation (“RGA”), as follows:

ITEM 4.  PURPOSE OF TRANSACTION.

     Item 4 is hereby amended by replacing the final sentence of the third paragraph with the following:

     “On January 25, 2006, Lisa M. Weber resigned from her position on the Board of Directors of RGA. On January 26, 2006, Georgette A. Piligian was elected as a director of RGA. On January 18, 2007, Leland C. Launer, Jr. resigned from his position as chairman of the Board of Directors of RGA. On January 25, 2007, Steven A. Kandarian was elected as a director and as chairman of the Board of Directors of RGA.”

     Item 4 is hereby further amended by replacing the penultimate paragraph thereof with the following:

     “As previously disclosed, the Filing Parties continuously evaluate RGA’s businesses and prospects, alternative investment opportunities and other factors deemed relevant in determining whether additional Shares will be acquired by any of the Filing Parties or whether any of the Filing Parties will dispose of Shares. At any time, depending on certain factors including market conditions, trading prices for the Shares and of the securities of MLINC, actions taken by the Board of Directors of RGA, alternative investment opportunities and the outlook for RGA, the Filing Parties and other industry participants, one or more of the Filing Parties may acquire additional Shares or may dispose of some or all of the Shares beneficially owned by such Filing Parties, in either case in the open market, in privately negotiated transactions or otherwise. In this connection, the Filing Parties are examining certain alternatives for the disposition of all of the Shares held by the Filing Parties, including a tax-free exchange of all or substantially all of such Shares with MLINC securityholders and a sale of all or substantially all of such Shares to a third party. There is no assurance that the Filing Parties will determine to or agree with any other person to effect any transaction relating to the Shares or otherwise, nor as to the terms of any such transaction.”

ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.

     Item 5 is hereby amended by replacing the first sentence of the first paragraph of Item 5(a) and (b) with the following:

     “(a) and (b). As of February 22, 2008, each of the Filing Parties beneficially owned 32,243,539 Shares, or approximately 52 percent of the outstanding Shares.”

     Item 5 is hereby further amended by replacing the last paragraph of Item 5(a) and

6

(b) with the following:

     “The percentage amounts set forth in this Item 5 are based upon 62,001,463 Shares issued and outstanding as of October 31, 2007, as reported in RGA’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2007.”

     Item 5 is hereby further amended by removing the second paragraph of Item 5(a) and 5(b).

ITEM 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO THE SECURITIES OF THE ISSUER.

     Item 6 is hereby amended by removing the last paragraph of Item 6.

ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS.

Exhibit	Description of Exhibits
99.1	Directors and Executive Officers of the Filing Parties
99.9	Agreement Required for Joint Filing Under Rule 13d-1(k)(1)

7

    SIGNATURE

 After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 22, 2008

METLIFE, INC. 

By:    /s/ Joseph J. Prochaska, Jr.         

         Name: Joseph J. Prochaska, Jr. 

         Title: Executive Vice President and Chief Accounting Officer 

METROPOLITAN LIFE INSURANCE COMPANY  

By:    /s/ Joseph J. Prochaska, Jr.         

         Name: Joseph J. Prochaska, Jr. 

         Title: Executive Vice President and Chief Accounting Officer  

GENAMERICA FINANCIAL, LLC 

By: Metropolitan Life Insurance Company, its Manager   

By:    /s/ Joseph J. Prochaska, Jr.         

         Name: Joseph J. Prochaska, Jr. 

         Title: Executive Vice President and Chief Accounting Officer 

GENERAL AMERICAN LIFE INSURANCE COMPANY 

By:    /s/ Joseph J. Prochaska, Jr.          

         Name: Joseph J. Prochaska, Jr. 

         Title: Executive Vice President and Chief Accounting Officer

8

EX-99.1

Exhibit 99.1

Directors and Executive Officers of the Filing Parties

Set forth below is the name and present principal occupation or employment of each director and executive officer of MLINC and MetLife. MLINC is a holding company and MetLife is an insurance company. The principal business address of MLINC and MetLife is 200 Park Avenue, New York, NY 10166-0188. Unless otherwise noted, the business address of each of the directors and executive officers is c/o MetLife, Inc. Each person listed below is a citizen of the United States.

Directors

Name and Business Address	Principal Occupation or Employment
Sylvia Mathews Burwell The Bill and Melinda Gates Foundation 1551 Eastlake Avenue East Seattle, Washington 98102	President of the Global Development Program at the Bill and Melinda Gates Foundation
Burton A. Dole, Jr.	Retired Chairman of Dole/Neal LLC (privately-held energy management firm), and retired Partner and Chief Executive Officer of MedSouth Therapy Associates, LLC (rehabilitative health care)
Cheryl W. Grise	Retired Executive Vice President of Northeast Utilities (public utility holding company)
C. Robert Henrikson	Chairman, President and Chief Executive Officer, MLINC and MetLife
James R. Houghton Corning Incorporated  80 E. Market Street  Suite 201  Corning, New York 14830	Chairman Emeritus and Director of Corning Incorporated (global technology)
R. Glenn Hubbard Dean’s Office Columbia Business School Uris Hall 3022 Broadway New York, New York 10027	Dean of the Graduate School of Business at Columbia University (business school)
Helene L. Kaplan Skadden, Arps, Slate, Meagher & Flom LLP Four Times Square New York, New York 10036	Of Counsel, Skadden, Arps, Slate, Meagher & Flom LLP (law firm)
John M. Keane 2020 K Street N.W. Suite 300 Washington, DC 20006	Co-Founder and Senior Managing Director of Keane Advisors, LLC (private equity investment firm)

Name and Business Address	Principal Occupation or Employment
James M. Kilts Centerview Partners Management, LLC 16 School St. Rye, NY 10580	Partner, Centerview Partners Management, LLC (financial advisory firm)
Charles M. Leighton US SAILING 15 Maritime Drive Portsmouth, Rhode Island 02871	Executive Director of US SAILING
Hugh B. Price Brookings Institution 1775 Massachusetts Avenue, NW Washington, D.C. 20036	Senior Fellow, Brookings Institution
David Satcher Morehouse School of Medicine 720 Westview Drive SW Atlanta, Georgia 30310-1495	Director of the Satcher Health Leadership Institute and the Center of Excellence on Health Disparities at the Morehouse School of Medicine
Kenton J. Sicchitano	Retired Global Managing Partner of PricewaterhouseCoopers, LLP (assurance, tax and advisory services)
William C. Steere, Jr. Pfizer Inc. 235 East 42nd Street, 22nd Floor New York, New York 10017	Retired Chairman of the Board and Chief Executive Officer of Pfizer Inc.

2

Executive Officers (who are not directors)
Name	Principal Occupation or Employment
Ruth A. Fattori	Executive Vice President and Chief Administrative Officer, MLINC and MetLife
Steven A. Kandarian	Executive Vice President and Chief Investment Officer, MLINC and MetLife
James L. Lipscomb	Executive Vice President and General Counsel, MLINC and MetLife
Maria R. Morris	Executive Vice President, Technology and Operations, MLINC and MetLife
William J. Mullaney	President, Institutional Business, MLINC and MetLife
Catherine A. Rein	Senior Executive Vice President, MLINC and MetLife
William J. Toppeta	President, International, MLINC and MetLife
Lisa M. Weber	President, Individual Business, MLINC and MetLife
William J. Wheeler	Executive Vice President and Chief Financial Officer, MLINC and MetLife

GenAm Financial is a holding company. The principal business address of GenAm Financial is One MetLife Plaza, 27-01 Queens Plaza North, Long Island City, New York 11101. GenAm Financial is a limited liability company with MetLife serving as its Manager. The directors and executive officers of MetLife are listed above.

3

Set forth below is the name and present principal occupation or employment of each director and executive officer of GenAm Life. GenAm Life is an insurance company. The principal business address of GenAm Life is 13045 Tesson Ferry Road, St. Louis, Missouri 63128. Unless otherwise noted, the business address for each of the directors and executive officers is c/o MetLife, Inc. Each person listed below is a citizen of the United States.

Name and Business Address	Principal Occupation or Employment
Mark K. Farrell 10 Park Avenue Morristown, New Jersey 07962	Senior Vice President, MetLife; Director, GenAm Life
James L. Lipscomb	Executive Vice President and General Counsel, MLINC and MetLife; Director, GenAm Life
William J. Mullaney	President, Institutional Business, MLINC and MetLife; Director, GenAm Life
Joseph J. Prochaska, Jr.	Executive Vice President and Chief Accounting Officer, MLINC, MetLife and GenAm Life
Catherine A. Rein	Senior Executive Vice President, MLINC and MetLife; Director, GenAm Life
Eric T. Steigerwalt	Senior Vice President and Treasurer, MLINC, MetLife and GenAm Life; Director, GenAm Life
Stanley J. Talbi	Executive Vice President, MetLife; Director, GenAm Life
Michael J. Vietri	Director, GenAm Life
Lisa M. Weber	President, Individual Business, MLINC and MetLife; Chairman of the Board, President, Chief Executive Officer and Director, GenAm Life
William J. Wheeler	Executive Vice President and Chief Financial Officer, MLINC and MetLife; Director, GenAm Life

4

EX-99.9

Exhibit 99.9

Joint Filing Agreement

In accordance with Rule 13d-1(k)(1) of Regulation 13D-G of the Securities Exchange Act of 1934, the persons or entities below agree to the joint filing on behalf of each of them of the Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock of Reinsurance Group of America, Incorporated, and agree that such statement is, and any amendments thereto filed by any of them will be, filed on behalf of each of them, and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings.

Dated: February 22, 2008

METLIFE, INC. 

By:    /s/ Joseph J. Prochaska, Jr.        

         Name: Joseph J. Prochaska, Jr.
            Title: Executive Vice President and Chief Accounting Officer

METROPOLITAN LIFE INSURANCE COMPANY 

By:    /s/ Joseph J. Prochaska, Jr.        

         Name:  Joseph J. Prochaska, Jr.
            Title:  Executive Vice President and Chief Accounting Officer

GENAMERICA FINANCIAL, LLC 

By: Metropolitan Life Insurance Company, its Manager 

By:    /s/ Joseph J. Prochaska, Jr.        

         Name:  Joseph J. Prochaska, Jr.
            Title:  Executive Vice President and Chief Accounting Officer  

GENERAL AMERICAN LIFE INSURANCE COMPANY   

By:    /s/ Joseph J. Prochaska, Jr.        

            Name:  Joseph J. Prochaska, Jr.
            Title:  Executive Vice President and Chief Accounting Officer